0001209191-20-047352.txt : 20200818
0001209191-20-047352.hdr.sgml : 20200818
20200818201609
ACCESSION NUMBER: 0001209191-20-047352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200818
FILED AS OF DATE: 20200818
DATE AS OF CHANGE: 20200818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klencke Barbara
CENTRAL INDEX KEY: 0001647647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37490
FILM NUMBER: 201115056
MAIL ADDRESS:
STREET 1: C/O PRONAI THERAPEUTICS, INC.
STREET 2: 2150 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sierra Oncology, Inc.
CENTRAL INDEX KEY: 0001290149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
BUSINESS PHONE: 604-558-6536
MAIL ADDRESS:
STREET 1: 2150 ? 885 WEST GEORGIA STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 3E8
FORMER COMPANY:
FORMER CONFORMED NAME: ProNAi Therapeutics Inc
DATE OF NAME CHANGE: 20040513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-18
0
0001290149
Sierra Oncology, Inc.
SRRA
0001647647
Klencke Barbara
C/O SIERRA ONCOLOGY, INC.
2150 885 WEST GEORGIA ST.
VANCOUVER
A1
V6C 3E8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Development Officer
Common Stock
2020-08-18
4
P
0
5950
12.2201
A
10000
D
Common Stock
2020-08-18
4
P
0
3325
12.2519
A
5000
I
By spouse
Represents the weighted average purchase price. The lowest price at which shares were purchased was $12.21 and the highest price at which shares were purchased was $12.23. The reporting person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the issuer or its stockholders, full information regarding the total number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.
Represents the weighted average purchase price. The lowest price at which shares were purchased was $12.22 and the highest price at which shares were purchased was $12.30.
/s/ Sukhi Jagpal as attorney-in-fact for Barbara Klencke, M.D.
2020-08-18